NCT03494660View on ClinicalTrials.gov

SCP Hip Outcomes Study

Active, not recruitingOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

October 9, 2024

Study Completion Date

December 31, 2025

Conditions
Subchondral CystsSubchondral Bone EdemaBone Marrow EdemaInsufficiency FracturesAvascular Necrosis of HipFemoroacetabular ImpingementDysplasia; Hip
Interventions
DEVICE

Subchondroplasty Procedure with AccuFill

Injection of the commercially available flowable calcium phosphate (CaP) synthetic bone-void filler, AccuFill®, into subchondral bone defects in the hip (Subchondroplasty (SCP) Procedure).

Trial Locations (6)

32561

Andrews Research & Education Foundation, Gulf Breeze

40506

University of Kentucky Research Foundation, Lexington

43202

The Ohio State University, Columbus

44195

Cleveland Clinic Foundation, Cleveland

61114

OrthoIllinois, Rockford

92270

Eisenhower Desert Orthopedic Center, Rancho Mirage

Sponsors

Lead Sponsor

Zimmer Biomet
All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY